- AngioDynamics press release ( NASDAQ: ANGO ): Q2 Non-GAAP EPS of $0.01 beats by $0.02 .
- Revenue of $85.4M (+9.1% Y/Y) beats by $1.02M .
-
Fiscal Year 2023 Financial Guidance: Management is reaffirming its previously issued fiscal year 2023 guidance. Management expects net sales to be in the range of $342 to $348 million vs consensus of $342.48M, gross margin to be approximately 52.5% to 54.5% and adjusted earnings per share in the range of $0.01 to $0.06 as it continues to invest in new product launches to drive future growth vs consensus of $0.01.
For further details see:
AngioDynamics Non-GAAP EPS of $0.01 beats by $0.02, revenue of $85.4M beats by $1.02M, reaffirms fiscal year 2023 outlook